Skip to search formSkip to main contentSkip to account menu

reveromycin A

Known as: reveromycin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Background: Fatty acyl-CoA ligases involved in polyketide biosynthesis remain uncharacterized. Results: RevS classified in fatty… 
2012
2012
In osteoprotegerin-deficient (OPG−/−) mice, osteoclast activity causes bone resorption to outpace bone formation, leading to the… 
2012
2012
Reveromycin A, a polyketide compound with a distinctive spiroacetal core structure (Figure 1), was isolated from Streptomyces… 
Review
2008
Review
2008
The mass and function of bones depends on the maintenance of a complicated balance between osteoclast-mediated bone resorption… 
2002
2002
Reveromycin A (Rev.A) is an inhibitor of epidermal growth factor-dependent cell growth that is produced from the culture broth of… 
2001
2001
The total synthesis of the epidermal growth factor inhibitor reveromycin B (2) in 25 linear steps from chiral methylene pyran 13… 
2000
2000
Our studies toward the total synthesis of the reveromycin family of natural products are described herein. Our synthetic approach… 
2000
2000
The stereoselective total synthesis of reveromycin A (1), a potent inhibitor of eukaryotic cell growth, has been accomplished on… 
2000
2000
[structure: see text] Reveromycin A (1) belongs to a family of microbial polyketides with unusual structural features and…